KLOW [TB10mg + BPC10mg + GHK50mg + KPV10mg] KIT (10 VIALS)

KLOW is a research peptide combination consisting of Thymosin Beta-4 (TB), BPC-157, GHK-Cu, and KPV that has attracted research interest for its potential effects on tissue repair, inflammatory signaling, cellular processes, and recovery-related pathways.

Research involving these individual peptides has explored mechanisms associated with cellular migration, angiogenesis, extracellular-matrix remodeling, oxidative stress, and inflammatory regulation.

TB and BPC-157 have been investigated in relation to tissue-repair and regenerative pathways, while GHK-Cu has been studied for its interactions with copper-dependent cellular processes, collagen synthesis, and skin and connective-tissue biology.

KPV, a peptide derived from α-melanocyte-stimulating hormone (α-MSH), has been investigated for its potential influence on inflammatory and immune signaling.

As a combined research formulation, KLOW remains of interest for studying complementary pathways related to tissue integrity, inflammation, recovery, and cellular repair.

Notable Research:
Goldstein AL, et al. — Research on Thymosin Beta-4 and its role in cellular migration, angiogenesis, and tissue repair.
Gong C, et al. — Research investigating BPC-157 and mechanisms associated with tissue repair and inflammatory regulation.
Pickart L, et al. — Research on GHK-Cu and its role in connective-tissue remodeling, collagen synthesis, and cellular signaling.
Getting SJ, et al. — Research on KPV and α-MSH–derived peptides in inflammatory and immune signaling pathways.